STAMFORD, Conn., Oct. 3 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH) today announced that a consolidated preliminary injunction hearing and trial on the merits in Delcath's federal securities lawsuit against Laddcap Value Partners LP has been scheduled by the Honorable Loretta A. Preska of the U.S. District Court for the Southern District of New York to commence on November 6, 2006 at 10:00 a.m. Pending the Court's decision following the consolidated preliminary injunction hearing and trial, the parties are prohibited from taking any further action on the consents or consent revocations they have obtained. As previously announced, Judge Preska has found that Delcath has "a likelihood of success on the merits of its [Section] 13(d) and 14(a) claims" against Laddcap.

About Delcath Systems, Inc.

Delcath Systems is a developer of isolated perfusion technology for organ or region-specific delivery of therapeutic agents. The Company's intellectual property portfolio currently consists of 12 patents on a worldwide basis, including the United States, Europe, Asia and Canada. For more information, please visit the Company's website, www.delcath.com.

This release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to our ability to successfully complete Phase III clinical trials and secure regulatory approval of our current or future drug-delivery system and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the date they are made.

    Company Contact:                      Investor Contacts:
    Delcath Systems, Inc.                 Todd Fromer / Garth Russell
    M. S. Koly, Chief Executive Officer   KCSA Worldwide
                               / 
    www.delcath.com                        / 

    Media Contacts:
    Lewis Goldberg
    KCSA Worldwide
    
    

SOURCE Delcath Systems, Inc.